SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy

SummaryIn the areas of chemotherapy, targeted therapy and immunotherapy, several interesting and clinically relevant data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS). This short review focuses on dose-dense and/or sequential administration of adjuvant chemotherapy, provides an update on targeted therapies for HER2-positive and triple-negative breast cancer and summarizes new results in the field of immunotherapy.

http://link.springer.com/10.1007/s12254-018-0430-0

Source: Memo - Magazine of European Medical Oncology - August 17, 2018 Category: Cancer & Oncology Source Type: research